Cancer has long been understood as a disease intrinsically linked to the passage of time. The cumulative effect of cellular damage over decades is a primary driver of tumor development, making age a significant risk factor. However, a concerning trend is emerging: cancer is being diagnosed with increasing frequency in younger adults, and each successive generation appears to be facing a heightened risk compared to those who came before. This phenomenon has spurred intense scientific inquiry into a provocative hypothesis: are younger generations accumulating biological damage at a faster rate, effectively aging their bodies prematurely?
New evidence from a groundbreaking study led by researchers at Washington University School of Medicine in St. Louis provides compelling support for this hypothesis. The findings suggest that younger generations are, in fact, aging more rapidly on a biological level than previous generations did at comparable chronological ages. This accelerated biological aging, the study indicates, is intricately connected to a greater susceptibility to early-onset cancers, defined as those diagnosed at age 55 or younger.
The implications of this research are profound, potentially reshaping our understanding of cancer etiology and prompting a reevaluation of prevention and screening strategies. The study, published in the prestigious journal Nature Medicine, is the culmination of extensive international collaborative efforts, involving researchers from the Siteman Cancer Center at Barnes-Jewish Hospital and WashU Medicine, as well as the global Cancer Grand Challenges initiative, co-founded by the National Cancer Institute and Cancer Research U.K.
The Widening Chasm: Biological Age vs. Chronological Age
The distinction between chronological age and biological age is crucial to understanding these findings. Chronological age is a simple measure of the years a person has lived. Biological age, conversely, is a more complex indicator that reflects the physiological state of the body, assessed through measurable changes in cells, organs, metabolic processes, and other vital systems. It represents how "old" a body truly is at a cellular and functional level, irrespective of the calendar.
The Washington University-led study observed a significant correlation: as the discrepancy between a person’s biological age and their chronological age widened, their risk of developing cancer increased. Critically, individuals from more recent birth cohorts exhibited larger gaps between their biological and chronological ages compared to those born in earlier eras. This suggests that, at the same chronological age, younger individuals’ bodies are exhibiting signs of greater biological wear and tear. This generational divergence in biological aging could be a significant contributing factor to the observed rise in cancer incidence among younger adults.
Organ-Specific Aging and Cancer Links
Further analysis revealed that the accelerated aging process did not affect all organ systems uniformly. The study identified specific links between the accelerated aging of particular bodily systems and the development of certain types of early-onset cancers. For instance, an immune system that displayed markers of advanced biological aging was associated with an increased risk of early-onset lung cancer. Similarly, fat tissue exhibiting signs of premature aging was linked to a higher likelihood of developing early-onset colorectal cancer. These findings underscore the intricate interplay between systemic and organ-level biological processes and cancer susceptibility.
Toward Personalized Prevention: Identifying High-Risk Individuals
The researchers posit that measurements of accelerated biological aging could become a valuable tool for clinicians in the future. By identifying younger individuals who exhibit unusually high rates of biological aging, healthcare providers could potentially intervene earlier with targeted prevention strategies and more proactive screening protocols.
"Our ultimate goal is to decode how modern environments become biologically embedded to drive cancer risk, transforming prevention from broad recommendations to personalized interventions," stated Yin Cao, ScD, a leading molecular epidemiologist and an associate professor of surgery and of medicine at WashU Medicine, who spearheaded the research. "This brings us closer to identifying risk earlier and developing prevention strategies that are tailored to an individual’s biology." This sentiment highlights a paradigm shift in cancer care, moving beyond a one-size-fits-all approach towards precision medicine.
Deconstructing the Trend: Beyond Individual Risk Factors
Prior research by Cao’s team has meticulously examined numerous factors known to influence cancer risk throughout an individual’s lifespan. These include obesity, metabolic dysregulation, alcohol consumption, sedentary lifestyles, poor dietary habits, and even the mode of delivery (cesarean section). While each of these factors provides valuable insights into why cancer might develop at younger ages, no single factor has proven sufficient to explain the overall escalating trend.
This realization led Cao and her colleagues to seek a more comprehensive approach – a method for quantifying the combined impact of multiple influences that interact over time to elevate cancer susceptibility. Support from the Cancer Grand Challenges initiative, a global collaboration focused on tackling the most formidable challenges in cancer research, has been instrumental in enabling Cao, as co-lead of Team PROSPECT, to investigate this complex question on an unprecedented scale.
The Data Foundation: UK Biobank and All of Us Research Program
The foundation of this pivotal study rests on the analysis of vast datasets. Researchers examined data from over 154,000 young adults enrolled in the UK Biobank, a comprehensive resource containing extensive biological, health, and lifestyle information. Complementing this, they also analyzed data from more than 10,000 participants in the United States who are part of the National Institutes of Health’s (NIH) All of Us Research Program. This ambitious initiative aims to build a diverse and comprehensive health database of over one million individuals living across the U.S.
Quantifying Biological Aging: Systemic and Organ-Specific Measures
To precisely measure biological aging, the research team, with first author Ruiyi Tian, a doctoral student in the Cao lab, employed two distinct methodologies. The first focused on "systemic aging," which assesses the aging process across the body as a whole. The second delved into "organ-specific aging," designed to estimate the rate at which individual organs or biological systems are aging.
For systemic aging, the researchers utilized established approaches that leverage clinical biomarkers. These included PhenoAge, a well-regarded measure of biological age based on blood biochemistry markers, and the Klemera-Doubal Method, another validated approach. Additionally, they incorporated a metabolomic age score, specifically developed to capture age-related patterns in an individual’s metabolism. PhenoAge, for instance, relies on nine blood biochemistry markers such as albumin (produced by the liver) and creatinine (a waste product filtered by the kidneys) to estimate biological age.
To assess organ-specific aging, the team analyzed blood proteomic data. Proteomics involves measuring the levels of numerous proteins associated with particular organ systems. These protein patterns were then used to derive an estimated biological age for individual organs.
The researchers calculated the average difference between biological and chronological age within distinct birth cohorts. Subsequently, they employed standard deviation – a statistical measure indicating the degree of dispersion or spread of data points around the average – to quantify how much each group deviated from the overall study average. This rigorous statistical approach allowed for a precise comparison of aging rates across different generations.
Generational Discrepancies Emerge
The analysis revealed striking generational differences in biological aging profiles, consistently observed in both the UK and U.S. participant populations.
In the UK cohort, individuals born between 1965 and 1974 demonstrated systemic aging that was 23% of one standard deviation higher than those born between 1950 and 1954, even after controlling for chronological age. This translates to younger generations exhibiting a demonstrably older biological profile at the same chronological age.
The disparity was even more pronounced in the U.S. data. Participants born between 1990 and 1999 showed systemic aging that was 92% of one standard deviation higher compared to those born between 1965 and 1969. These figures represent a substantial acceleration in biological aging for the youngest cohorts studied.
The Cancer Connection: Accelerated Aging and Increased Risk
The critical question then became whether these observed differences in biological aging were indeed linked to cancer incidence. The study confirmed a significant association: greater systemic aging in younger cohorts was correlated with an 8% increased risk of early-onset solid cancers. The strongest associations were observed with lung, gastrointestinal, and uterine cancers.
Further stratification of participants into three groups based on their level of systemic aging revealed an even clearer pattern. Individuals with the most advanced systemic aging experienced a 15% elevated risk of early-onset solid cancer when compared to participants exhibiting the least advanced aging. Importantly, this association persisted even after accounting for well-established factors such as inherited genetic predispositions to cancer and genetic susceptibility to accelerated aging itself.
Delving into individual biological systems further elucidated these connections. Advanced aging of the immune system was linked to a higher risk of early-onset lung cancer, while accelerated aging of adipose (fat) tissue was associated with an increased risk of early-onset colorectal cancer. These organ-specific findings highlight the complex, multi-systemic nature of cancer development.
"If we can identify younger people with the highest cancer risk when they are still healthy, we can focus on prevention and early-detection strategies for the individuals who will benefit most from early interventions," Dr. Cao emphasized, underscoring the potential clinical utility of this research.
Unraveling the "Why": Environmental and Societal Influences
This research is a core component of Team PROSPECT, a collaborative effort within the Cancer Grand Challenges framework. Cancer Grand Challenges is a global research initiative co-funded by Cancer Research UK and the National Cancer Institute (NCI). It unites scientists from diverse specialties and geographical locations to confront the most intractable problems in cancer research.
One such formidable problem is understanding the escalating prevalence of early-onset cancers globally. "Right now, we don’t have a definitive answer to what’s driving the rise of early-onset cancers around the world, but studies like this are helping us piece together the bigger picture, showing that cancer may be influenced not just by changes inside individual cells, but by wider changes happening across the body as a whole," commented David Scott, PhD, Director of Cancer Grand Challenges. "Research on this scale is possible through Cancer Grand Challenges, which brings together scientists from different fields around the world to tackle these complex questions together."
Cao and her team are actively pursuing a deeper understanding of the underlying causes behind cancer’s increasing impact on younger generations. A primary focus is to determine how environmental shifts, evolving lifestyles, and societal changes may be leaving enduring biological imprints on the human body. These effects could manifest as accelerated aging and other vulnerabilities that predispose individuals to disease. By tracing the accumulation of these risks throughout a person’s life, researchers aim to illuminate the biological origins of early-onset cancers.
The ultimate aspiration of this research extends beyond mere comprehension of why cancer is appearing earlier. It aims to proactively identify individuals at elevated risk while they are still in good health. This would enable a paradigm shift towards earlier prevention and screening, allowing for personalized interventions that halt disease development before it begins, thereby transforming cancer care into a proactive, preventative discipline.
The research was supported by grants from Cancer Research UK, the National Cancer Institute (NCI) of the NIH, the French National Cancer Institute, and the Bowelbabe Fund for Cancer Research UK. Additional support was provided by grants from the NIH/National Institute of Diabetes and Digestive and Kidney Diseases, the Alvin J. Siteman Cancer Center, and various training programs at Washington University School of Medicine in St. Louis. The content reflects the sole responsibility of the authors and does not necessarily represent the official views of the NIH.
